A consumer-led global pharmaceutical company, creating healthy doses of life since 1949. When you operate in an industry like pharmaceuticals, your work goes way beyond creating ‘products for customers’. It is different from any other domain – there lies a higher sense of responsibiliti and a need for utmost integriti in everything you do. As you serve millions of lives, high qualiti standards become a pre-requisite, and safeti of your people and consumers always comes first. All this, while ensuring that each life you touch is treated with respect and digniti. This, is how Ipca works. For more than 60 years, Ipca has been a crucial healthcare partner in over 120 countries across the 6 continents. We are a fully-integrated pharmaceutical company that manufactures over 350 formulations and 80 APIs for various therapeutic segments. Today, we are one of the world’s largest manufacturers and suppliers of over a dozen APIs. These are produced from scratch at fully-automated manufacturing facilities, approved by the world’s most discerning drug regulatory authorities like UK-MHRA, EDQM-Europe, and WHO-Geneva, among others. Taking the industry forward
Ipca ventured into Ophthalmology in the year 2014, with an aim to serve the ophthalmic fraternity with innovative formulations for helping millions to see a better tomorrow. It started with the launch of Aquasurge (CMC 0.5%) and Aquasurge Max (CMC 1%) followed by Moxisurge (Moxifloxacin 0.5%) and Bromvue (Bromfenac 0.09%) The journey has been progressive and Ipca Optima has been jumping ranks in IQVIA ranking in ophthalmology. Today it stands as the fastest growing ophthalmic company amongst the top 21 companies. Ipca Optima has completed more than 5 years of it’s operations and has got accolade even from "All India Ophthalmological Society" for the best trade participation in the year 2019. Overall the journey has been very encouraging and looking forward we aim to serve ophthalmology with products and services with an aim to create a distinct mark for ourselves amongst ophthalmic companies.
'Vision' is a single word which means a world to everyone. We understand that eyes are a sensitive organ and we at Ipca|Optima put patient's first in everything we do and hence today we have formulations which are designed keeping the need of patient’s in mind. "Eyesurge" has been a unique antioxidant formulation launched for the first time in India, which was formulated as per the guidelines of ARED’s-2 study which was launched in small size tablet from a vegetarian source for once a day administration, for improving patient compliance. It also comes with a unique patient education booklet which helps the patient to understand the disease of ARMD, Diabetic Retinopathy, Cataract and glaucoma and comply to the treatment of the doctor. We not only manufacture formulations, but package it with a service proposition for patients wherein in "Hylosurge" we have incorporated a QR code on each and every pack so that when the patient scans it he/she has access to videos on “How to instill eye drops" and "Eye Exercises" for improving ocular health in 13 different languages. With an intent to improve compliance in patients for the use of steroids which is challenging fo the patient’s we have incorporated a unique dosage calendar for the first time in India for one complete month in each and every pack of our product “Lotesurge” and “Lotesurge –LS” We have launched BAK free formulations, Moxisurge-D, Moxisurge-L and Bromvue which are cornea friendly to patients. We are committed to support the cause of wellness, prevention, treatment and cure in broad range of therapeutic areas in ophthalmology and are committed toward delivering formulations which you can trust.